PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
Rhea-AI Summary
PacBio (NASDAQ: PACB) will hold a quarterly conference call to discuss its second quarter 2026 financial results on Wednesday, August 5, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). Investors can listen live or via replay through PacBio’s investor relations website or by using the provided toll-free and international dial-in numbers.
Positive
- None.
Negative
- None.
News Market Reaction – PACB
In the Jul 16 session, PACB declined 2.61%, reflecting a moderate negative market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 16 | Earnings date notice | Neutral | +3.7% | Announced Q1 2026 results call on May 7, 2026 at 4:30 p.m. ET. |
| Jan 27 | Earnings date notice | Neutral | -7.4% | Set Q4 and full-year 2025 results call for February 12, 2026 at 5:00 p.m. ET. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings date announcements have produced mixed single-day reactions, with an average move of about -1.85% across recent events.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2026 financial results on Wednesday, August 5, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
The call will be webcast and may be accessed on PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Wednesday, August 5, 2026, at 4:30 p.m. ET (1:30 p.m. PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
